, Tracking Stock Market Picks
Enter Symbol:

up 2,913.20 %

PHARMASSET INC. (VRUS) rated Outperform with price target $34 by Wedbush Morgan

Posted on: Wednesday,  Oct 21, 2009  9:25 AM ET by Wedbush Morgan

Wedbush Morgan rated Outperform PHARMASSET INC. (NASDAQ: VRUS) on 10/21/2009. Previously Wedbush Morgan rated Buy PHARMASSET INC. (NASDAQ: VRUS) on 03/18/2009.,
when the stock price was $4.55. Since then, PHARMASSET INC. has gained 2913.20% as of 01/17/2012's recent price of $136.95.
If you would have followed the previous Wedbush Morgan's recommendation on VRUS, you would have gained 2913.2% of your investment in 1035 days.

Pharmasset, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of drugs to treat viral infections. It focuses on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).

Since 1980, WEDBUSH has used its private equity discipline to invest in under-valued and capital constrained public and private companies that have a significant potential for appreciation. The firm invests with high quality management teams with domain expertise and expects management to retain or make a personally significant equity investment.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/21/2009 9:25 AM Buy
10.00 17.00
as of 12/31/2009
1 Week up  140.48 %
1 Month up  143.37 %
3 Months up  130.13 %
1 YTD up  143.25 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/18/2009 9:25 AM Buy
4.55 9.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy